Athira Pharma, Inc.
Total Trades
60
Buys
12
Sells
20
Largest Trade
N/A
Insiders
13
Institutional Funds
5
Inst. Value
$500K+
Activist Filings
21
Insider Trades
| Insider | Title | Type | Value | Shares | Price | Date |
|---|---|---|---|---|---|---|
| San Martin Javier | CHIEF MEDICAL OFFI… | EXERCISE | N/A | 5K | — | Jan 6, 2026 |
| San Martin Javier | CHIEF MEDICAL OFFI… | SELL | $1K–$15K | 2K | $6.88 | Jan 6, 2026 |
| Litton Mark James | President and CEO | EXERCISE | N/A | 11K | — | Jan 6, 2026 |
| Litton Mark James | President and CEO | SELL | $15K–$50K | 3K | $6.88 | Jan 6, 2026 |
| Renninger Robert | CFO | SELL | $1K–$15K | 297 | $6.88 | Jan 6, 2026 |
| Renninger Robert | CFO | EXERCISE | N/A | 1K | — | Jan 6, 2026 |
| Renninger Robert | CFO | GRANT | $1K–$15K | 1K | $2.31 | Jan 6, 2026 |
| CHURCH KEVIN | CHIEF SCIENTIFIC O… | EXERCISE | N/A | 4K | — | Jan 6, 2026 |
| CHURCH KEVIN | CHIEF SCIENTIFIC O… | GRANT | $1K–$15K | 1K | $2.31 | Jan 6, 2026 |
| CHURCH KEVIN | CHIEF SCIENTIFIC O… | SELL | $1K–$15K | 876 | $6.88 | Jan 6, 2026 |
| Worthington Mark | General Counsel an… | SELL | $1K–$15K | 876 | $6.88 | Jan 6, 2026 |
| Worthington Mark | General Counsel an… | EXERCISE | N/A | 4K | — | Jan 6, 2026 |
| CHURCH KEVIN | CHIEF SCIENTIFIC O… | GRANT | $1K–$15K | 10K | $0.23 | Jul 2, 2025 |
| CHURCH KEVIN | CHIEF SCIENTIFIC O… | SELL | $1K–$15K | 9K | $0.29 | Jul 2, 2025 |
| CHURCH KEVIN | CHIEF SCIENTIFIC O… | EXERCISE | N/A | 37K | — | Jul 2, 2025 |
| Litton Mark James | President and CEO | EXERCISE | N/A | 108K | — | Jul 2, 2025 |
| Litton Mark James | President and CEO | SELL | $1K–$15K | 25K | $0.29 | Jul 2, 2025 |
| San Martin Javier | CHIEF MEDICAL OFFI… | SELL | $1K–$15K | 11K | $0.29 | Jul 2, 2025 |
| San Martin Javier | CHIEF MEDICAL OFFI… | EXERCISE | N/A | 47K | — | Jul 2, 2025 |
| Worthington Mark | General Counsel an… | SELL | $1K–$15K | 9K | $0.29 | Jul 2, 2025 |
| Worthington Mark | General Counsel an… | EXERCISE | N/A | 37K | — | Jul 2, 2025 |
| Renninger Robert | SVP | EXERCISE | N/A | 12K | — | Jul 2, 2025 |
| Renninger Robert | SVP | SELL | <$1K | 3K | $0.29 | Jul 2, 2025 |
| Renninger Robert | SVP | GRANT | $1K–$15K | 10K | $0.23 | Jul 2, 2025 |
| San Martin Javier | CHIEF MEDICAL OFFI… | EXERCISE | N/A | 47K | — | Jan 3, 2025 |
| San Martin Javier | CHIEF MEDICAL OFFI… | SELL | $1K–$15K | 11K | $0.56 | Jan 3, 2025 |
| Litton Mark James | President and CEO | SELL | $1K–$15K | 25K | $0.56 | Jan 3, 2025 |
| Litton Mark James | President and CEO | EXERCISE | N/A | 108K | — | Jan 3, 2025 |
| CHURCH KEVIN | CHIEF SCIENTIFIC O… | EXERCISE | N/A | 37K | — | Jan 3, 2025 |
| CHURCH KEVIN | CHIEF SCIENTIFIC O… | SELL | $1K–$15K | 9K | $0.56 | Jan 3, 2025 |
| CHURCH KEVIN | CHIEF SCIENTIFIC O… | GRANT | $1K–$15K | 10K | $0.55 | Jan 3, 2025 |
| Renninger Robert | VP of Finance | EXERCISE | N/A | 12K | — | Jan 3, 2025 |
| Renninger Robert | VP of Finance | SELL | $1K–$15K | 3K | $0.56 | Jan 3, 2025 |
| Renninger Robert | VP of Finance | GRANT | $1K–$15K | 4K | $0.55 | Jan 3, 2025 |
| Worthington Mark | General Counsel an… | GRANT | $1K–$15K | 4K | $0.55 | Jan 3, 2025 |
| Worthington Mark | General Counsel an… | EXERCISE | N/A | 37K | — | Jan 3, 2025 |
| Worthington Mark | General Counsel an… | SELL | $1K–$15K | 9K | $0.56 | Jan 3, 2025 |
| Romano Kelly A | Director | BUY | $100K–$500K | 42K | $2.36 | Jun 25, 2024 |
| PERCEPTIVE ADVISORS LLC | Director | BUY | $1M+ | 606K | $2.42 | Dec 29, 2023 |
| Gengos Andrew | See Below | BUY | $50K–$100K | 15K | $3.43 | Jun 9, 2023 |
| Gengos Andrew | See Below | BUY | $100K–$500K | 65K | $2.95 | Jun 6, 2023 |
| PICKERING GRANT | Director | BUY | $50K–$100K | 25K | $2.41 | Mar 31, 2023 |
| JOHNSON JAMES A | Director | BUY | $1K–$15K | 5K | $2.40 | Mar 30, 2023 |
| MILESON GLENNA | CFO | BUY | $100K–$500K | 50K | $2.85 | Dec 30, 2022 |
| MILESON GLENNA | CFO | GRANT | $1K–$15K | 763 | $2.74 | Dec 30, 2022 |
| Romano Kelly A | Director | BUY | $50K–$100K | 30K | $3.29 | Dec 7, 2022 |
| MOEBIUS HANS | Chief Medical Offi… | BUY | $15K–$50K | 5K | $3.29 | Nov 18, 2022 |
| PERCEPTIVE ADVISORS LLC | Director | BUY | $1M+ | 1.4M | $2.99 | Jul 1, 2022 |
| MOEBIUS HANS | Chief Medical Offi… | BUY | $15K–$50K | 10K | $2.88 | Jun 30, 2022 |
| Worthington Mark | General Counsel | GRANT | $15K–$50K | 13K | $1.79 | Jun 24, 2022 |
Institutional Ownership
13F filings as of Sep 30, 2025 · 5 funds holding
| Fund | Shares | Value | Type |
|---|---|---|---|
| Simplify Asset Management Inc. | 149K | $500K+ | SH |
| American Capital Advisory, LLC | 200 | <$1K | SH |
| McIlrath & Eck, LLC | 82 | <$1K | SH |
| Global Retirement Partners, LLC | 52 | <$1K | SH |
| Global Retirement Partners, LLC | 52 | <$1K | SH |
| JPMORGAN CHASE & CO | 12 | <$1K | SH |
Activist & 5%+ Owners
SC 13D/13G filings — investors holding 5%+ of outstanding shares
SC 13G/A · Jan 8, 2026
2.6%
250K shares
SC 13G · Dec 23, 2025
2.2%
211K shares
SC 13G/A · Dec 18, 2025
0.0%
0 shares
SC 13G/A · Oct 10, 2025
4.1%
161K shares
SC 13G · Apr 16, 2025
5.1%
2.0M shares
SC 13G/A · Feb 14, 2025
7.2%
2.8M shares
SC 13G/A · Feb 14, 2025
5.8%
2.2M shares
SC 13G/A · Nov 14, 2024
0.0%
0 shares
SC 13G · Nov 7, 2024
5.8%
2.2M shares
SC 13D/A · Oct 31, 2024
540.3M shares
SC 13G · Feb 14, 2024
8.3%
3.2M shares
SC 13D/A · Dec 29, 2023
14.2%
5.4M shares
SC 13G/A · Jul 7, 2023
1.8%
670K shares
SC 13G · Apr 20, 2023
5.3%
2.0M shares
SC 13G/A · Feb 14, 2023
0.0%
0 shares
SC 13G/A · Feb 1, 2023
6.2%
2.4M shares
SC 13G/A · Jan 30, 2023
0.0%
0 shares
SC 13D/A · Jul 1, 2022
12.8%
4.8M shares
SC 13G/A · Feb 14, 2022
0.0%
0 shares
Venrock Healthcare Capital Partners II, L.P.
SC 13G/A · Feb 14, 2022
2.7%
1.0M shares
SC 13G/A · Feb 14, 2022
5.1%
1.9M shares